Should I take a COVID-19 rapid antigen test? Part 1 in a Series
Testing and Contact Tracing
Chana Davis, PhD
Should I take a rapid antigen test before visiting a vulnerable person (e.g. an immunocompromised parent)? What about before hosting a gathering or attending a big event? The short answer: Yes, yes, and yes! ⌛ Shortest post ever. JK. There is always nuance to consider when we talk about testing, because no test is perfect. Read more…
Boosters for Pfizer/BioNTech approved for large group of Americans.
Vaccines
Jennifer Beam Dowd, PhD
DC Director overrules ACIP and also includes those at high risk due to occupational exposures. Update from this week’s ACIP meeting: ➡️ ACIP recommended 3rd doses for Pfizer/BioNTech recipients 65+ more than 6 months past their 2nd dose, and for persons 18-64 with underlying medical conditions. ➡️ ACIP voted NO on boosters based on occupational Read more…
Should I take a rapid antigen test before visiting a vulnerable person (e.g. an immunocompromised parent)? What about before hosting a gathering or attending a big event? The short answer: Yes, yes, and yes! ⌛ Shortest post ever. JK. There is always nuance to consider when we talk about testing, because no test is perfect. Read more…
Boosters for Pfizer/BioNTech approved for large group of Americans.
VaccinesJennifer Beam Dowd, PhD
DC Director overrules ACIP and also includes those at high risk due to occupational exposures. Update from this week’s ACIP meeting: ➡️ ACIP recommended 3rd doses for Pfizer/BioNTech recipients 65+ more than 6 months past their 2nd dose, and for persons 18-64 with underlying medical conditions. ➡️ ACIP voted NO on boosters based on occupational Read more…
DC Director overrules ACIP and also includes those at high risk due to occupational exposures. Update from this week’s ACIP meeting: ➡️ ACIP recommended 3rd doses for Pfizer/BioNTech recipients 65+ more than 6 months past their 2nd dose, and for persons 18-64 with underlying medical conditions. ➡️ ACIP voted NO on boosters based on occupational Read more…
